» Articles » PMID: 39742240

Hemodynamics in Left-Sided Cardiomyopathies

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiomyopathies, historically regarded as rare, are increasingly recognized due to advances in imaging diagnostics and heightened clinical focus. These conditions, characterized by structural and functional abnormalities of the myocardium, pose significant challenges in both chronic and acute patient management. A thorough understanding of the hemodynamic properties, specifically the pressure-volume relationships, is essential. These relationships provide insights into cardiac function, including ventricular compliance, contractility, and overall cardiovascular performance. Despite their potential utility, pressure-volume curves are underutilized in clinical settings due to the invasive nature of traditional measurement techniques. Recognizing the dynamic nature of cardiomyopathies, with possible transitions between phenotypes, underscores the importance of continuous monitoring and adaptive therapeutic strategies. Enhanced hemodynamic evaluation can facilitate tailored treatment, potentially improving outcomes for patients with these complex cardiac conditions.

References
1.
Brannagan T, Coelho T, Wang A, Polydefkis M, Dyck P, Berk J . Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update. J Neurol. 2022; 269(12):6416-6427. PMC: 9618524. DOI: 10.1007/s00415-022-11276-8. View

2.
Sherrid M . Drug Therapy for Hypertrophic Cardiomypathy: Physiology and Practice. Curr Cardiol Rev. 2016; 12(1):52-65. PMC: 4807719. DOI: 10.2174/1573403x1201160126125403. View

3.
Berlin D, Bakker J . Starling curves and central venous pressure. Crit Care. 2015; 19:55. PMC: 4329649. DOI: 10.1186/s13054-015-0776-1. View

4.
Diez-Villanueva P, Vicent L, de la Cuerda F, Esteban-Fernandez A, Gomez-Bueno M, de Juan-Baguda J . Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure and Reduced Ejection Fraction Treated with Sacubitril/Valsartan. Cardiology. 2020; 145(5):275-282. DOI: 10.1159/000505148. View

5.
Geske J, Sorajja P, Ommen S, Nishimura R . Variability of left ventricular outflow tract gradient during cardiac catheterization in patients with hypertrophic cardiomyopathy. JACC Cardiovasc Interv. 2011; 4(6):704-9. DOI: 10.1016/j.jcin.2011.02.014. View